Data obtained from H&E and immunohistochemical (IHC) staining indicated that XMU‐MP‐5 dose‐dependently inhibited ALK activity and induced tumor cell apoptosis in vivo, as indicated by the decreased ALK phosphorylation level and the induction of caspase‐3 cleavage, respectively (Fig 2G). Here, ALK is linked to neoplasm.